Sign In
Buy XRAY
$9.88
+0.240 (+2.49%)
At Close: Jun 04, 2026
DENTSPLY SIRONA (XRAY) Falls After Nasdaq's Delinquency Notice
09:02am, Wednesday, 17'th Aug 2022
The Nasdaq exchange issues a notice to DENTSPLY SIRONA (XRAY) for filing delinquency from the exchange and for non-compliance with the Nasdaq Listing Rules. Shares fall.
Vascular Biogenics (VBLT) Reports Q2 Loss, Misses Revenue Estimates
09:35pm, Monday, 15'th Aug 2022 Zacks Investment Research
Vascular Biogenics (VBLT) delivered earnings and revenue surprises of 7.69% and 57.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Dentsply Sirona Receives Notice of Filing Delinquency from Nasdaq
08:30pm, Monday, 15'th Aug 2022 GlobeNewswire Inc.
CHARLOTTE, N.C., Aug. 15, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that, as expected, it received written notification fr
DENTSPLY SIRONA (XRAY) Up on Strong Q2 Preliminary Results
01:26pm, Tuesday, 09'th Aug 2022 Zacks Investment Research
DENTSPLY SIRONA's (XRAY) preliminary second-quarter 2022 results reflect the normalizing business, aided by product launches and pricing adjustments. Shares rise.
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022
02:43pm, Friday, 05'th Aug 2022 Benzinga
Upgrades
For 8x8 Inc (NYSE:EGHT), Craig-Hallum upgraded the previous rating of Hold to Buy. In the first quarter, 8x8 showed an EPS of $0.09, compared to $0.01 from the year-ago quarter. At the moment
Dentsply Sirona Provides Business Update
08:30pm, Thursday, 04'th Aug 2022 GlobeNewswire Inc.
Company Provides Select Preliminary Second Quarter 2022 Results
AmerisourceBergen (ABC) Q3 Earnings and Revenues Surpass Estimates
11:45am, Wednesday, 03'rd Aug 2022 Zacks Investment Research
AmerisourceBergen (ABC) delivered earnings and revenue surprises of 1.95% and 1.47%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
What 4 Analyst Ratings Have To Say About Dentsply Sirona
01:49pm, Thursday, 21'st Jul 2022 Benzinga
Dentsply Sirona (NASDAQ:XRAY) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
2
1
0
0
Last
Here's Why You Should Buy DENTSPLY SIRONA (XRAY) Stock Now
03:03pm, Thursday, 14'th Jul 2022 Zacks Investment Research
DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, forex woes persist.
Here's Why You Should Buy DENTSPLY SIRONA (XRAY) Stock Now
12:24pm, Thursday, 14'th Jul 2022
DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, forex woes persist.
Is McKesson (MCK) a Great Value Stock Right Now?
01:40pm, Tuesday, 12'th Jul 2022 Zacks Investment Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Dividend Champion, Contender, And Challenger Highlights: Week Of July 3
06:49am, Sunday, 03'rd Jul 2022 Seeking Alpha
Click here to read the weekly summary of dividend activity for Dividend Champions, Contenders, Challengers.
Stocks This Week: Sell Short Dentsply Sirona And Ebay
08:21pm, Sunday, 12'th Jun 2022
Short selling has worked well over the last two weeks. Here are two more recommendations.
Why Is Dentsply (XRAY) Up 6.2% Since Last Earnings Report?
03:30pm, Thursday, 09'th Jun 2022 Zacks Investment Research
Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Dentsply (XRAY) Up 6.2% Since Last Earnings Report?
12:47pm, Thursday, 09'th Jun 2022
Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock?
